Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Response to Tomsak, R. PDE5 inhibitors and permanent visual loss (Int J Impot Res 2005; 17: 547-549).

Watt SJ, Primatesta P, Siegel R.

Int J Impot Res. 2006 Jul-Aug;18(4):411; author reply 412. No abstract available.

PMID:
16819534
2.

Non-arteritic anterior ischemic optic neuropathy, erectile dysfunction drugs, and amiodarone: is there a relationship?

Fraunfelder FW, Shults T.

J Neuroophthalmol. 2006 Mar;26(1):1-3. No abstract available.

PMID:
16518158
3.

Stepwise decline in visual field after serial sildenafil use.

Pepin S, Pitha-Rowe I.

J Neuroophthalmol. 2008 Mar;28(1):76-7. doi: 10.1097/WNO.0b013e31816743da. No abstract available.

PMID:
18347466
4.

Visual loss with erectile dysfunction medications.

Wooltorton E.

CMAJ. 2006 Aug 15;175(4):355. Epub 2006 Jul 26. No abstract available.

5.

Sildenafil-associated NAION.

Gandhi JS.

Ophthalmology. 2003 Sep;110(9):1860-1; author reply 1861. No abstract available.

PMID:
13129901
6.
7.

FDA updates labeling for erectile dysfunction drugs.

[No authors listed]

FDA Consum. 2005 Sep-Oct;39(5):3. No abstract available.

8.

Rates of non-arteritic ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors.

Tsertsvadze A.

Am J Ophthalmol. 2009 Oct;148(4):625; author reply 625-6. doi: 10.1016/j.ajo.2009.06.026. No abstract available.

PMID:
19782802
9.

Viagra and loss of vision.

[No authors listed]

Med Lett Drugs Ther. 2005 Jun 20;47(1211):49. No abstract available.

PMID:
15961969
10.

Ophthalmic aspects of erectile dysfunction drugs.

Verit A, Oguz H.

Am J Ophthalmol. 2006 Mar;141(3):598; author reply 599. No abstract available.

PMID:
16490529
11.

Can erectile dysfunction drug use lead to ischaemic optic neuropathy?

Pomeranz HD.

Br J Ophthalmol. 2006 Feb;90(2):127-8. No abstract available.

12.

NAION and treatment of erectile dysfunction: reply from Pfizer.

Sobel RE, Cappelleri JC.

Br J Ophthalmol. 2006 Jul;90(7):927. No abstract available.

14.

Sildenafil-associated nonarteritic anterior ischemic optic neuropathy.

Pomeranz HD, Smith KH, Hart WM Jr, Egan RA.

Ophthalmology. 2002 Mar;109(3):584-7.

PMID:
11874765
15.
16.

Bilateral posterior ischemic optic neuropathy associated with use of sildenafil.

Su DH, Ang PS, Tow SL.

J Neuroophthalmol. 2008 Mar;28(1):75. doi: 10.1097/WNO.0b013e318167554a. No abstract available.

PMID:
18347465
17.

Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy.

Gorkin L, Hvidsten K, Sobel RE, Siegel R.

Int J Clin Pract. 2006 Apr;60(4):500-3.

18.

Unilateral optic neuropathy associated with sildenafil intake.

Gruhn N, Fledelius HC.

Acta Ophthalmol Scand. 2005 Feb;83(1):131-2. No abstract available.

19.

Sildenafil associated anterior ischaemic optic neuropathy.

Dheer S, Rekhi GS, Merlyn S.

J Assoc Physicians India. 2002 Feb;50:265. No abstract available.

PMID:
12038660
20.

Ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors.

Margo CE, French DD.

Am J Ophthalmol. 2007 Mar;143(3):538-9. Epub 2006 Nov 13.

PMID:
17317413

Supplemental Content

Support Center